Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: The Stop Atherosclerosis in Native Diabetics Study (SANDS)
- 30 June 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Lipidology
- Vol. 4 (3), 165-172
- https://doi.org/10.1016/j.jacl.2010.01.008
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (1U01 HL67031-01A1)
- National Institutes of Health
This publication has 27 references indexed in Scilit:
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes—the Stop Atherosclerosis in Native Diabetics Study (SANDS)American Heart Journal, 2006
- Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 DiabetesDiabetes Care, 2006
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patientsJournal of Affective Disorders, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- A Comprehensive League Table of Cost-Utility Ratios and a Sub-table of "Panel-worthy" StudiesMedical Decision Making, 2000
- Economic Analyses of Diabetes InterventionsThe Endocrinologist, 1999
- Five‐Hundred Life‐Saving Interventions and Their Cost‐EffectivenessRisk Analysis, 1995
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995